Latest filing published 07 Mar 2023 for Avanos Medical, INC., €42k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
William David Haydon: trading record in brief
This profile gathers the share dealings of William David Haydon in Avanos Medical, Inc., where the filings describe the role as chief executive. The record holds 4 filings, for trades running from 31 August 2020 to 6 March 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 7 March 2023 came the latest disclosure, a share grant for €42k in Avanos Medical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William David Haydon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,513 shares@ US$29.62100.0% of flowCommon StockSEC:0001606498-23-000025:0
- 12,949 shares0Common StockSEC:0001606498-22-000036:0
2 of 2 declarations
